1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Glossary of Hostile Takeover Terms with Discussion

Discussion in 'Allergan' started by Shoham, Jun 13, 2014 at 2:08 AM.

  1. anonymous

    anonymous Guest

    We have no R&D left! Mostly everyone was laid off.
     
  2. Shoham

    Shoham Member

    Joined:
    Jun 9, 2014
    Messages:
    236
    Likes Received:
    0
    That, I feel, is the heart of the problem. Dan.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    They have been criminally bad in defending Allergan interests. Allergan was poised to purchase Shire but didn't and missed out on their new dry eye product. Now. Instead of making a deal with revance for a next gen Botox they missed that opportunity also.

    They definitely seem some better or faster business advisors.
     
  5. Shoham

    Shoham Member

    Joined:
    Jun 9, 2014
    Messages:
    236
    Likes Received:
    0
    Headline update:

    Tanner (Valeant) and Davenport (Philidor CEO) were convicted of fraud.

    https://www.bloomberg.com/news/arti...ecutive-guilty-of-taking-pharmacy-ceo-s-bribe

    As the long-time readers of this thread may remember, those two (along with Pearson, Schiller, and Shacknai) were on my list of those I expected to end in Prison.

    However, I think that what they were convicted of they were innocent of (well, 'innocent' may not be the best word here); and the real crime hasn't been prosecuted (yet?).

    Imagine a mob boss paying a hit man $10K to kill someone. Neither the hit man nor the mobster are ever prosecuted for the murder, but since the hit man can't give any credible answer as to why he was paid $10K, he is convicted of stealing (defrauding) the money from the mobster (who is suddenly a victim in this narrative!). In my book, they are both guilty of murder, but the hit man didn't "steal" any money from the mobster; he received it for services rendered (as criminal as those services were). This is basically what happened, in my view, here.

    Philidor was never a legitimate business. It always was an insurance fraud front for Valeant. It pretended to be a pharmacy (an organization licensed to act in the interest of patients) while actually being an arm of a drug maker (acting in the opposite interest). Insurers were being fooled, pressured, and defrauded to cover not-particularly-effective $1000 branded ointments -- often on never-asked-for auto-refill plans -- when more effective $10 generic options were available. Overall, by my guess, about $2B were stolen from insurers before Philidor imploded.

    To a certain degree, the Philidor (very temporary) success fueled Valeant's attempt to acquire Allergan (my opinion). And, to a lesser extent, the uncompromising Allergan defense helped start the process that eventually unmasked Philidor. Valeant, according to some of the publicly available documents I read when I was engaged in this story, was pleasantly shocked with just how much Philidor was bringing in, and figured (my opinion) that important segments of the Allergan product portfolio were just perfect for the Philidor method. They planned to acquire Allergan and then make a killing by Philidor-izing the product portfolio. Allergan knew about Philidor and just how sleazy it was. Allergan very lightly worked some of that into it's anti-Valeant story, but stopped at saying that Valeant was increasing its profit through unwarranted and unsustainable price hikes of existing products (which Philidor certainly made more possible) rather than going all out and claiming insurance fraud. It wasn't until about a year afterward when independent journalists uncovered (what Allergan already knew and never fully leveraged) the Philidor story that the full implosion took place.

    I have sometimes wondered, in the "what-if" world of alternative history, if Allergan missed a killer defense opportunity. We now know that Wall Street didn't have a clue about Philidor (before the implosion, I automatically assumed that it did -- Philidor wasn't a secret -- Allergan knew about it, the doctors knew about it, even I knew about it and I'm not even in the industry; and no one who knew about Philidor thought of it as anything other than a Valeant front). We also know that as soon as Wall Street found out about Philidor, Valeant imploded even faster and more forcefully (total-dollar-wise) than Enron did two decades before. One has to wonder what would have happened if Allergan forcefully pointed attention to Philidor.
    (To be fair, John Hempton, an Australian tax investigator turned hedge fund manager, did figure enough of this out to short Valeant while the Allergan battle was ongoing, and he did write about it in his newsletter at the time; his fund, Bronte Capital, ended up making $5M on the short sale -- which is a ridiculously small profit to be made when you are the first to foresee a $90B collapse!)

    But, back to the newly convicted.
    While Philidor was pretending to be a Pharmacy, and not an arm of a drug maker, it had a nominal CEO -- Davenport. But the man really in charge was a Valeant executive (Tanner). Ostensibly, Valeant had no ownership interest in Philidor; but through a series of shell companies and "zero-priced options", it had full control. (The whole concept of ZPO -- the right to buy an asset for $0 -- does not pass the accounting smell test, in my opinion; if you purchase the right to buy something for $0, you own it; don't pretend otherwise) Tanner and others used a whole ensemble of subterfuges and slights of hand (like using fake email aliases) to avoid (in their mind) generating a paper trail of the Valeant control of Philidor; but no one was even pretending to be fooled. Everyone who knew Philidor, knew it was controlled by Valeant (even if they didn't know or care about the legalese of the mechanism). Tanner and Davenport were handsomely rewarded for the services they were performing for Valeant. Davenport got $50M for those ZPOs. Since Valeant couldn't directly pay Tanner -- their own employee -- for the equity of Philidor (an ostensibly independent company), they had Davenport pass $10M of the $50M he got to Tanner. Considering that Philidor was bringing in something like $2B in (insurance fraud) money to Valeant, paying $50M to the executives who made it work was just a modest bonus.
    But then, when the investigators arrived, rather than zeroing in on the $2B insurance fraud (maybe that's still in the works, idk, I'm only opining from what we know now), they asked about those payments. The $50M from Valeant to Davenport, that could be explained. Davenport was selling them ZPOs in Philidor (whether one considers ZPOs as options or as selling the company is beside the point, Davenport was selling something real -- the Philidor equity -- for the $50M). The $10M from Davenport to Tanner, like the payment from a mobster to a hit man, that couldn't be explained. If Tanner is a Valeant employee, and Philidor is not a part of Valeant, then Tanner shouldn't be paid by Valeant for the equity in Philidor. The real explanation, that Tanner was controlling Philidor on behalf of Valeant and was being paid for that, like the real explanation that the hit man didn't steal the money from the mobster but earned it fair and square (ish), could not be used in any legal setting.
    So, again, like the hit man being convicted of stealing money from the mobster, Tanner was convicted of stealing the $10M from Valeant. According to the conviction, Tanner was controlling Valeant (or, at least influencing it, with respect to Philidor) on behalf of Philidor and was paid a $10M bribe for his services (whereas, in actuality, the line of control was in exactly the opposite direction -- Tanner was controlling Philidor on behalf of Valeant and was paid a bonus for doing such a great job).

    I suppose it's still possible, between now and sentencing, that our convicted "hit man", in exchange for a reduced sentence and no further prosecution against him, will testify that he didn't steal the money from the mobster, but rather was paid a fee for committing a murder ordered by the mob boss -- and thus get the mob boss convicted of murder. Or, in this situation, have Tanner and Davenport admit that Valeant was paying them to push Valeant products under the guise of being an independent pharmacy.

    We shall see.

    Have a great Memorial Day, everyone!

    Dan.
     
  6. Shoham

    Shoham Member

    Joined:
    Jun 9, 2014
    Messages:
    236
    Likes Received:
    0
  7. anonymous

    anonymous Guest

  8. anonymous

    anonymous Guest

    As much as I like to see the bad players of Valeant get cooked, I am more concerned about how poorly AGN is run by Saunders and his ego. Currently Tepper has taken a stance on getting change at the management level due to lack of a better word, "incompetence" by Saunders and his management team. Market value of AGN has gone from $110 Billion to around $51 Billion under Saunders with no bottom in sight. Change in control by a new CEO with a proven record of success needs to happen in my opinion. Too many retirement funds have been damaged changing the future of many hard working people who have invested in what was a very good company.
     
  9. anonymous

    anonymous Guest

  10. anonymous

    anonymous Guest

    Dan - please give us your insights into what’s going on? The bleed in the stock price is shocking. Were we that overvalued? Is there anyway this can turn around? This has all been very disappointing.
     
  11. anonymous

    anonymous Guest

    Dan
    Opinion on the buy out by Abbvie?